logo
May 11 - 13, 2020 | Las Vegas

The Emerald Group

Booth: 517

Emerald is focused on the development of pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the endocannabinoid system. The near-term investment opportunities within our portfolio are: Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF), a licensed producer of cannabis for medical and recreational purposes; Emerald Bioscience (OTCQB: EMBI), a biopharmaceutical company developing cannabinoid-based therapeutics; and Emerald Health Pharmaceuticals, a pre-IPO biopharmaceutical company developing treatments for autoimmune diseases.

Speaker Schedule

Enhancing Health Through Cannabis Science
May 13, 2019, 10:45 am - 11:05 am PDT

Presented by: Allan Rewak

Focus: CANNABIS INVESTMENTS